• Gordon Fox

    CEO, Emblem Corp.

    Mr. Fox is a former partner at Goodman & Carr LLP, where from 1979 to 1995 he practiced securities law. Gordon is a Co-Founder of White Cedar Pharmacy, serving over 2,600 patients in Ontario. He also founded Lytton Capital—a Limited Market Dealer—in 1995.

  • Harvey Shapiro

    CEO, GrowWise Health

    Co-founder & CEO of Dynacare (1988 – 2002) – A TSX listed medical diagnostic services company. Acquired by Laboratory Corp. of America in 2002. Harvey also practiced Securities Law at Goodman & Carr LLP from 1973 to 1987. Harvey is closely connected within the Canadian pharmacy community.

  • John Stewart

    CEO, Pharmaceutical Division

    Mr. Stewart is former President and CEO of Purdue Pharma Canada (1991-2006) and Purdue Pharma USA (2007-2013), one of the largest privately-held pharmaceutical companies in the world. John launched 11 new products, including Ms Contin, OxyContin and Biphentin. John has extensive experience in formulation development, clinical trials and medical communications.

  • John Laurie


    Mr. Laurie is former Treasurer and CFO with a number of Canadian public & private companies. Previously with Moore Wallace and George Weston Limited, John brings a broad range of financial experience including budgeting and budgetary control, capital expenditure management, internal controls design and monitoring, cash flow modeling, tax, and risk management.

  • Maxim Zavet

    President, Emblem Cannabis

    As founding partner of Levy Zavet PC, Mr. Zavet carries extensive experience within the medical marijuana industry. From his knowledge of the ACMPR in Canada and his in-depth knowledge of medical marijuana to his vast, world-wide network of contacts, Maxim holds a first-rate comprehension of genetics, cultivation and he understands just about every aspect of the industry’s current and future needs.

  • Daniel Saperia


    Mr. Saperia commenced his career managing a boutique public accounting firm that serviced a group of very prestigious clients. He then served as President, and Chief Financial Officer for a period of fifteen years at two highly regarded international manufacturing companies. Mr. Saperia also continues to hold the position of President and Chief Operating Officer of a leading Specialty Pharmacy. Under his leadership, these companies developed reputations as industry leaders, while experiencing significant growth and enhanced financial performance.